Chiltern International Inc.
15
0
0
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
6.7%
1 terminated/withdrawn out of 15 trials
93.3%
+6.8% vs industry average
47%
7 trials in Phase 3/4
79%
11 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID)
Role: collaborator
P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne
Role: collaborator
P3 Study in Acne Comparing Once Daily SB204 and Vehicle
Role: collaborator
P3 Long Term Safety Study of Once Daily SB204 in Acne
Role: collaborator
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Role: collaborator
SI-613 Study for Knee Osteoarthritis
Role: collaborator
Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)
Role: collaborator
Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic Neuropathy
Role: collaborator
A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH
Role: collaborator
Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies
Role: collaborator
Trazodone in Painful Diabetic Neuropathy
Role: collaborator
Patient Registry Study of Berinert® in Normal Clinical Practice
Role: collaborator
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Role: collaborator
A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa
Role: collaborator
Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa
Role: collaborator
All 15 trials loaded